Identification of UBFD1 as a prognostic biomarker and molecular target among estrogen receptor-positive breast cancer
Article in Biochemical and Biophysical Research Communications (October 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score
Article in Cancer Medicine (July 2022)
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer
Article in Journal of Inflammation Research (June 2022)